DIAGNOS Inc. (ADK.V)
| Previous Close | 0.3550 |
| Open | 0.3650 |
| Bid | 0.3500 x 0 |
| Ask | 0.3550 x 0 |
| Day's Range | 0.3500 - 0.3650 |
| 52 Week Range | 0.1300 - 0.4400 |
| Volume | |
| Avg. Volume | 101,850 |
| Market Cap | 24.663M |
| Beta (5Y Monthly) | -0.08 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0400 |
| Earnings Date | Jan 25, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.00 |
- GlobeNewswire
DIAGNOS and ÉTS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of Contexts
Diagnos - Domain Adaptation Method Diagnos - Domain Adaptation Method BROSSARD, Quebec, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) is one of the leaders in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI). DIAGNOS and École de Technologie Supérieure (ÉTS), a world-renowned technical university, are proud to announce the unveiling of a method for adapt
- GlobeNewswire
DIAGNOS and ETS to Present Ground-breaking Research on Mass Screening for Macular Edema at ARVO 2023
Section of the eye Section of the eye BROSSARD, Quebec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) is a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI). DIAGNOS and École de Technologie Supérieure (ÉTS), a world-renowned technical university, are proud to announce that they will be presenting the results of their ground-breaking research on
- GlobeNewswire
DIAGNOS Announces Grant of Stock Options
BROSSARD, Quebec, Feb. 10, 2023 (GLOBE NEWSWIRE) -- February 10, 2023 – Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces the grant of an aggregate number of 1,275,000 stock options to its officers, employees, consultants and directors. Stock options vest at 50% per year, commencing with the first anniversary of the grant. Th
